NOTVHIGH SIGNALFINANCIAL10-K

NOTV experienced massive revenue growth of 511% alongside dramatic increases in current liabilities (368%) and accounts receivable (329%), suggesting potential acquisition activity or major business transformation with concerning liquidity implications.

The extraordinary financial changes - particularly the 5x revenue increase coupled with a 4x jump in current liabilities - indicate either a major acquisition or fundamental business restructuring that materially altered NOTV's financial profile. While revenue surged, the company remains deeply unprofitable with worsening operating cash flows, and the massive increase in current liabilities raises immediate liquidity concerns that investors must closely monitor.

Comparing 2025-12-05 vs 2024-12-04View on EDGAR →
FINANCIAL ANALYSIS

NOTV's financials show a dramatic transformation with revenue exploding 511% to $547.7M while current liabilities surged 368% to $556.8M, creating a precarious liquidity position where short-term obligations nearly equal total revenue. Despite the revenue boom, the company improved but remained deeply unprofitable with -$68.6M net income and worsening operating cash flows of -$10.5M. The massive increases in accounts receivable (329%) and inventory (152%) alongside reduced R&D spending suggest either major acquisition activity or significant business model changes that require careful monitoring given the deteriorating cash generation and liquidity metrics.

FINANCIAL STATEMENT CHANGES
Revenue
P&L
+511.2%
$89.6M→$547.7M

Strong top-line growth of 511.2% — accelerating demand or successful expansion into new markets.

Current Liabilities
Balance Sheet
+367.7%
$119.0M→$556.8M

Current liabilities surged 367.7% — significant near-term obligations; verify ability to meet short-term debt.

Accounts Receivable
Balance Sheet
+328.6%
$20.7M→$88.9M

Receivables surged 328.6% — revenue recognized but not yet collected; watch for collection issues or channel stuffing.

Inventory
Balance Sheet
+151.7%
$18.2M→$45.7M

Inventory surged 151.7% — growing significantly faster than typical sales pace; potential demand softening or supply chain overcorrection.

Gross Profit
P&L
+65.4%
$18.2M→$30.2M

Gross profit expanding — improving pricing power or product mix shift toward higher-margin offerings.

Operating Income
P&L
+64.2%
-$86.4M→-$30.9M

Operating leverage kicking in — revenue growth outpacing cost growth, a hallmark of scaling businesses.

R&D Expense
P&L
-57.4%
$950K→$405K

R&D spending cut 57.4% — could signal cost discipline or concerning reduction in innovation investment.

Operating Cash Flow
Cash Flow
-53.6%
-$6.8M→-$10.5M

Operating cash flow fell 53.6% — earnings quality concerns; investigate working capital changes and non-cash items.

Interest Expense
P&L
+44.8%
$29.7M→$43.0M

Interest expense surged 44.8% — significant debt increase or rising rates materially impacting earnings.

Net Income
P&L
+36.7%
-$108.4M→-$68.6M

Net income grew 36.7% — bottom-line growth signals improving overall business health.

LANGUAGE CHANGES
NEW — 2025-12-05
PRIOR — 2024-12-04
ADDED
As of November 21, 2025, 34,367,251 of the registrant s common shares were outstanding.
We have provided a summary of some of these risks below, with more information in Part I, Item 1A.
We have significant indebtedness, which may impair our ability to raise capital or impact our ability to service our debt.
Our management concluded that our disclosure controls and procedures and our internal control over financial reporting were not effective as of September 30, 2025 and as of prior dates due to material weaknesses in internal control over financial reporting.
Our business, results of operations, financial condition, including the carrying value of certain of our assets, and cash flows have been, and may continue to be, adversely affected by our dependence on the importation of non-human primates ("NHPs") from suppliers located outside the U.S., particularly from certain countries in Southeast Asia and Africa, legal issues related to these suppliers, increased costs associated with trade and economic factors, including tariffs, and any inability to diversify our suppliers located outside the U.S.
+7 more — sign up free →
REMOVED
As of November 15, 2024, 26,015,129 of registrant s common shares were outstanding.
If any of the events or circumstances described in Part I, Item 1A.
Our sales of non-human primates ("NHPs") have decreased significantly in recent periods, which adversely affected our business, financial condition and results of operations, and this trend may continue.
Our business, results of operations, financial condition, including the carrying value of certain of our assets, and cash flows have and may continue to be adversely affected by our dependence on the importation of NHPs from suppliers located outside the U.S., particularly from communist countries in Southeast Asia, legal issues related to these suppliers and any inability to diversify our suppliers located outside the U.S.
We have incurred significant additional indebtedness, which may impair our ability to raise further capital or impact our ability to service our debt.
+7 more — sign up free →
MORE FINANCIAL SIGNALS
PNRGHIGHPNRG achieved exceptional profitability improvement with net income surging 2,21...
2026-04-16
BNAIHIGHBNAI underwent a dramatic reverse stock split that reduced share count by 86% wh...
2026-04-16
LAKEHIGHLAKE's financial performance deteriorated significantly with operating losses wo...
2026-04-16
NXXTHIGHNextNRG experienced massive financial deterioration with operating losses explod...
2026-04-16
ANALYZE ANY FILING FREE

See what changed in your portfolio's filings

500+ US-listed companies analyzed. Language delta, financial analysis, instant signal scoring.

Try Tracenotes free →